SeekingAlpha · Aug 21, 2026
Schrodinger: The Software Business Is Stronger Than It Looks
Schrodinger (SDGR) stock rebounds amid revenue headwinds; new launches and collaborations support undervaluation thesis.
SD
NASDAQ · SDGR
Schrödinger, Inc.
Healthcare · Medical - Healthcare Information Services
$19.70
Down-$0.32 (-1.62%)
Updated Aug 31, 2026, 2:43 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.34B
- P/E ratio
- -7.34
- Dividend yield
- 0.00%
- 52-week range
- $10.95 – $20.48
- Volume
- 911.65K
- Avg. volume
- 1.08M
Price performance
SDGR price history
1M range · 20 trading sessions · Daily adjusted prices
SDGR closed at $19.70 after 20 trading sessions, up 28.93% for the selected period.
- Last close
- $19.70
- Period change
- +28.93%
- Period low
- $15.28
- Period high
- $20.41
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $20.20 | $20.33 | $19.53 | $19.70 | 911.65K |
| Aug 27, 2026 | $19.49 | $20.41 | $19.4885 | $20.41 | 863.13K |
| Aug 26, 2026 | $19.725 | $19.98 | $19.30 | $19.47 | 752.13K |
| Aug 25, 2026 | $18.95 | $20.18 | $18.8595 | $19.99 | 899.85K |
| Aug 24, 2026 | $19.61 | $19.61 | $18.70 | $18.77 | 914.55K |
| Aug 21, 2026 | $19.825 | $20.48 | $19.5101 | $19.71 | 1.1M |
| Aug 20, 2026 | $19.57 | $20.13 | $19.3112 | $19.58 | 1.03M |
| Aug 19, 2026 | $18.12 | $19.92 | $18.12 | $19.85 | 1.9M |
| Aug 18, 2026 | $17.31 | $17.715 | $17.17 | $17.67 | 841.09K |
| Aug 17, 2026 | $17.36 | $17.60 | $17.16 | $17.40 | 653.53K |
| Aug 14, 2026 | $18.46 | $18.495 | $17.58 | $17.59 | 948.8K |
| Aug 13, 2026 | $18.56 | $18.84 | $18.32 | $18.46 | 920.93K |
| Aug 12, 2026 | $18.60 | $18.73 | $18.21 | $18.63 | 1.48M |
| Aug 11, 2026 | $18.765 | $19.24 | $18.5973 | $18.65 | 1.43M |
| Aug 10, 2026 | $18.02 | $18.94 | $17.95 | $18.77 | 1.2M |
| Aug 7, 2026 | $18.08 | $18.85 | $17.485 | $18.16 | 1.37M |
| Aug 6, 2026 | $17.262 | $18.38 | $17.02 | $17.81 | 2.74M |
| Aug 5, 2026 | $15.75 | $16.485 | $15.5204 | $16.40 | 1.72M |
| Aug 4, 2026 | $15.30 | $15.745 | $15.20 | $15.65 | 971.1K |
| Aug 3, 2026 | $15.14 | $15.51 | $14.91 | $15.28 | 982.2K |
Latest SDGR news
The latest Smart Investors Daily articles mentioning SDGR.
Stock researchCompany · Overview
SDGR research
Overview
Company profile and research snapshot.
Company profile
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $19.00
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 14, 2026 | Morgan Stanley | Equal-Weight | — |
| Mar 17, 2026 | UBS | Neutral | — |
| Jan 8, 2026 | Keybanc | Overweight | — |
| Jan 8, 2026 | TD Cowen | Buy | — |
| Jan 7, 2026 | UBS | Neutral | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 6, 2026
Schrödinger, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-06. The following slide deck was published by Schrödinger, Inc.
SeekingAlpha · Aug 6, 2026
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsJaren Madden - Chief Corporate Affairs Officer & Head of...
ChartMill · Aug 6, 2026
Schrodinger (NASDAQ:SDGR) Q2 Results Beat Expectations; Guidance Raised
Schrödinger (SDGR) beats Q2 estimates with $58.9M revenue and $0.08 EPS, boosted by one-time Ajax gains; shares rise 3%.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
